BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8007471)

  • 21. The elevated interferon gamma production is an important immunological marker in HAM/TSP pathogenesis.
    Montanheiro PA; Penalva de Oliveira AC; Smid J; Fukumori LM; Olah I; da S Duarte AJ; Casseb J
    Scand J Immunol; 2009 Oct; 70(4):403-7. PubMed ID: 19751276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HTLV-1 proviral load in peripheral blood mononuclear cells quantified in 100 HAM/TSP patients: a marker of disease progression.
    Olindo S; Lézin A; Cabre P; Merle H; Saint-Vil M; Edimonana Kaptue M; Signate A; Césaire R; Smadja D
    J Neurol Sci; 2005 Oct; 237(1-2):53-9. PubMed ID: 15972218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ApaI polymorphism of vitamin D receptor gene is associated with susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis in HTLV-1 infected individuals.
    Saito M; Eiraku N; Usuku K; Nobuhara Y; Matsumoto W; Kodama D; Sabouri AH; Izumo S; Arimura K; Osame M
    J Neurol Sci; 2005 May; 232(1-2):29-35. PubMed ID: 15850579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation between polymorphisms at interleukin-6 but not at interleukin-10 promoter and the risk of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis in Brazilian individuals.
    Gadelha SR; Junior Alcântara LC; Costa GC; Acosta AX; Rios D; Kashima S; Covas DT; Galvão-Castro B
    J Med Virol; 2008 Dec; 80(12):2141-6. PubMed ID: 19040291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between HLA-DRB1*01 and HLA-Cw*08 and outcome following HTLV-I infection.
    Rafatpanah H; Pravica V; Faridhosseini R; Tabatabaei A; Ollier W; Poulton K; Thomson W; Hutchinson I
    Iran J Immunol; 2007 Jun; 4(2):94-100. PubMed ID: 17652849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased activated human T cell lymphotropic virus type I (HTLV-I) Tax11-19-specific memory and effector CD8+ cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with HTLV-I provirus load.
    Nagai M; Kubota R; Greten TF; Schneck JP; Leist TP; Jacobson S
    J Infect Dis; 2001 Jan; 183(2):197-205. PubMed ID: 11120926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymorphisms at GLUT1 gene are not associated with the development of TSP/HAM in Brazilian HTLV-1 infected individuals and the discovery of a new polymorphism at GLUT1 gene.
    Costa GC; Azevedo R; Gadelha SR; Kashima SH; Muricy G; Olavarria VN; Covas DT; Takayanagui OM; Galvão-Castro B; Alcantara LC
    J Med Virol; 2009 Mar; 81(3):552-7. PubMed ID: 19152396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human T lymphotropic virus type 1 (HTLV-1) proviral load in asymptomatic carriers, HTLV-1-associated myelopathy/tropical spastic paraparesis, and other neurological abnormalities associated with HTLV-1 infection.
    Silva MT; Harab RC; Leite AC; Schor D; Araújo A; Andrada-Serpa MJ
    Clin Infect Dis; 2007 Mar; 44(5):689-92. PubMed ID: 17278060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid syncytium formation between human T-cell leukaemia virus type-I (HTLV-I)-infected T-cells and human nervous system cells: a possible implication for tropical spastic paraparesis/HTLV-I associated myelopathy.
    Mor-Vaknin N; Turgeman H; Torgeman A; Wolfson M; Huleihel M; Aboud M
    Cell Biol Int; 1998; 22(2):95-103. PubMed ID: 9878096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased human T lymphotropic virus type I (HTLV-I) provirus load and alteration in T cell phenotype after interferon-alpha therapy for HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Saito M; Nakagawa M; Kaseda S; Matsuzaki T; Jonosono M; Eiraku N; Kubota R; Takenouchi N; Nagai M; Furukawa Y; Usuku K; Izumo S; Osame M
    J Infect Dis; 2004 Jan; 189(1):29-40. PubMed ID: 14702150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pulmonary involvement in patients with HTLV-I-associated myelopathy: increased soluble IL-2 receptors in bronchoalveolar lavage fluid.
    Sugimoto M; Nakashima H; Matsumoto M; Uyama E; Ando M; Araki S
    Am Rev Respir Dis; 1989 Jun; 139(6):1329-35. PubMed ID: 2786358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HTLV-I serostatus of mothers of patients with adult T-cell leukemia and HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Bartholomew C; Jack N; Edwards J; Charles W; Corbin D; Cleghorn FR; Blattner WA
    J Hum Virol; 1998; 1(4):302-5. PubMed ID: 10195256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuronal molecular mimicry in immune-mediated neurologic disease.
    Levin MC; Krichavsky M; Berk J; Foley S; Rosenfeld M; Dalmau J; Chang G; Posner JB; Jacobson S
    Ann Neurol; 1998 Jul; 44(1):87-98. PubMed ID: 9667596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accumulation of human T lymphotropic virus (HTLV)-I-specific T cell clones in HTLV-I-associated myelopathy/tropical spastic paraparesis patients.
    Höger TA; Jacobson S; Kawanishi T; Kato T; Nishioka K; Yamamoto K
    J Immunol; 1997 Aug; 159(4):2042-8. PubMed ID: 9257872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis, and adult T-cell leukemia/lymphoma.
    Giusti RM; Maloney EM; Hanchard B; Morgan OS; Steinberg SM; Wachter H; Williams E; Cranston B; Fuchs D; Manns A
    Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):699-704. PubMed ID: 8877061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HTLV-I in neurological diseases.
    Macchi B
    Ital J Neurol Sci; 1992 Dec; 13(9 Suppl 14):31-6. PubMed ID: 1345739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pulmonary involvement in human T-cell lymphotropic virus type-I uveitis: T-lymphocytosis and high proviral DNA load in bronchoalveolar lavage fluid.
    Sugimoto M; Mita S; Tokunaga M; Yamaguchi K; Cho I; Matsumoto M; Mochizuki M; Araki S; Takatsuki K; Ando M
    Eur Respir J; 1993 Jul; 6(7):938-43. PubMed ID: 8370441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pathogenesis of pulmonary involvement in HTLV-I-associated myelopathy (HAM): studies on T-cell function].
    Sugimoto M; Matsumoto M; Nakashima H; Imamura F; Kawano O; Imamura S; Fukuda Y; Ando M; Araki S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Oct; 27(10):1198-203. PubMed ID: 2615072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increase in T-cells bearing CD25 in bronchoalveolar lavage fluid from HAM/TSP patients and HTLV-I carriers.
    Mukae H; Kohno S; Morikawa N; Kadota J; Matsukura S; Hara K
    Microbiol Immunol; 1994; 38(1):55-62. PubMed ID: 8052162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [T-lymphocytosis and increased levels of soluble IL-2 receptors in bronchoalveolar lavage fluid in cases of HTLV-I-associated myelopathy with pulmonary involvement].
    Sugimoto M; Nakashima H; Matsumoto M; Kawano O; Imamura F; Ando M; Araki S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Apr; 27(4):481-7. PubMed ID: 2796057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.